Skip to content

Clinical trials

Phase 3 Scleroderma, Diffuse trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Phase: Phase 3 Country / region: France Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Bristol-Myers Squibb1
GlaxoSmithKline1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse5
Lung Diseases, Interstitial4
Scleroderma, Systemic3
Connective Tissue Diseases2
Pulmonary Fibrosis2
Arthritis, Rheumatoid1
Autoimmune Diseases1
Fibrosis1
Immune System Diseases1
Sarcoidosis1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.